The blockbuster success of the GLP-1 agonists and related drugs has renewed interest in peptide-based drugs, but how is the manufacturing technology evolving? In a CDMO roundtable, industry experts share their perspectives on the latest in peptide synthesis featuring Alaric Desmarchelier, PhD, Business Development Manager, Peptides, Almac Sciences, Mimoun Ayoub, PhD, Senior Vice President and Global Commercial Head of Peptides, CordenPharma, Matt Bio, PhD, Chief Scientific Officer, Cambrex, and Eric Fang, PhD, General Manager, Snapdragon Chemistry, Cambrex.

Each episode of the Production to Prescription podcast is housed on the DCAT Value Chain Insights website and also delivered through DCAT Value Chain Insights weekly email digest. Not a subscriber? Click here to subscribe to DCAT Value Chain Insights, or get each episode through: 

For a full list of the 2026 podcast episode schedule, click here.